Histopathology of central nervous system lesions in Behget's disease

被引:91
作者
Hirohata, Shunsei [1 ]
机构
[1] Kitasato Univ, Sch Med, Dept Rheumatol & Infect Dis, Kanagawa 2288555, Japan
关键词
Behcet's disease; central nervous system; histopathology; cerebrospinal fluid; IL-6;
D O I
10.1016/j.jns.2007.09.041
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Central nervous system (CNS) involvement in Behcet's disease, usually called neuro-Behcet's syndrome (NB), is one of the most serious complications of the disease. In the present study, we carried out immunohistological examination of biopsied or autopsied brain tissues from 3 patients with different types of NB, acute NB, chronic progressive NB, and NB in a long-term remission. Histopathology of mass lesion in acute NB revealed infiltration of mononuclear cells around small vessels, consisting of CD45RO+ T lymphocytes and CD68+ monocytes with few CD20+ B lymphocytes. Of interest, TUNNEL staining disclosed that most neurons were undergoing apoptosis in the inflammatory lesion. In chronic progressive NB, similar histopathological changes were noted in pons, cerebellum, medulla, internal capsule, and midbrain, although the degree of mononuclear cell infiltration was modest. There were also scattered foci of neurons undergoing apoptosis with formation of a few binucleated neurons. The most prominent feature of NB in a long-term remission was atrophy of basal pons with formation of cystic or moth-eaten lesions, consisting of isomorphic gliosis with viable neurons. There were still scattered foci of perivascular cuffing of T lymphocytes and monocytes. These results emphasize the common features throughout the courses of NB, perivascular cuffing of T lymphocytes and monocytes, irrespective of the clinical phenotypes. More importantly, it is suggested that soluble factors produced by infiltrating cells, including IL-6, might play a role in the induction of apoptosis of neurons in NB. (C) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:41 / 47
页数:7
相关论文
共 21 条
[1]   Clinical patterns of neurological involvement in Behcet's disease:: evaluation of 200 patients [J].
Akman-Demir, G ;
Serdaroglu, P ;
Tasçi, B .
BRAIN, 1999, 122 :2171-2181
[2]  
Aramaki Kaori, 2007, Mod Rheumatol, V17, P81, DOI 10.1007/s10165-006-0541-z
[3]   Interleukin-6 (IL-6) - A molecule with both beneficial and destructive potentials [J].
Gadient, RA ;
Otten, UH .
PROGRESS IN NEUROBIOLOGY, 1997, 52 (05) :379-390
[4]   Purkinje neuron physiology is altered by the inflammatory factor interleukin-6 [J].
Gruol, DL ;
Nelson, TE .
CEREBELLUM, 2005, 4 (03) :198-205
[5]  
Hadfield MG, 1997, CLIN NEUROPATHOL, V16, P55
[6]   Progressive decline in avoidance learning paralleled by inflammatory neurodegeneration in transgenic mice expressing interleukin 6 in the brain [J].
Heyser, CJ ;
Masliah, E ;
Samimi, A ;
Campbell, IL ;
Gold, LH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (04) :1500-1505
[7]   Cerebrospinal fluid interleukin-6 in progressive neuro-Behcet's syndrome [J].
Hirohata, S ;
Isshi, K ;
Oguchi, H ;
Ohse, T ;
Haraoka, H ;
Takeuchi, A ;
Hashimoto, T .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1997, 82 (01) :12-17
[8]   Low-dose weekly methotrexate for progressive neuropsychiatric manifestations in Behcet's disease [J].
Hirohata, S ;
Suda, H ;
Hashimoto, T .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1998, 159 (02) :181-185
[9]   Behcet's disease [J].
Hirohata, S ;
Kikuchi, H .
ARTHRITIS RESEARCH & THERAPY, 2003, 5 (03) :139-146
[10]   IL-6 induces regionally selective spinal cord injury in patients with the neuroinflammatory disorder transverse myelitis [J].
Kaplin, AI ;
Deshpande, DM ;
Scott, E ;
Krishnan, C ;
Carmen, JS ;
Shats, I ;
Martinez, T ;
Drummond, J ;
Dike, S ;
Pletnikov, M ;
Keswani, SC ;
Moran, TH ;
Pardo, CA ;
Calabresi, PA ;
Kerr, DA .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (10) :2731-2741